JP2009529868A5 - - Google Patents

Download PDF

Info

Publication number
JP2009529868A5
JP2009529868A5 JP2008558940A JP2008558940A JP2009529868A5 JP 2009529868 A5 JP2009529868 A5 JP 2009529868A5 JP 2008558940 A JP2008558940 A JP 2008558940A JP 2008558940 A JP2008558940 A JP 2008558940A JP 2009529868 A5 JP2009529868 A5 JP 2009529868A5
Authority
JP
Japan
Prior art keywords
fragment
seq
strain
polynucleotide
mutation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008558940A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009529868A (ja
JP5923232B2 (ja
Filing date
Publication date
Priority claimed from CA002538898A external-priority patent/CA2538898A1/fr
Priority claimed from CA 2545597 external-priority patent/CA2545597A1/en
Application filed filed Critical
Publication of JP2009529868A publication Critical patent/JP2009529868A/ja
Publication of JP2009529868A5 publication Critical patent/JP2009529868A5/ja
Application granted granted Critical
Publication of JP5923232B2 publication Critical patent/JP5923232B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008558940A 2006-03-15 2007-03-15 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用 Active JP5923232B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CA2,538,898 2006-03-15
CA002538898A CA2538898A1 (fr) 2006-03-15 2006-03-15 Nouvelles souches isolees et purifiees du virus chikungunya et sequences nucleotidiques et peptidiques, applications diagnostiques et immunogeniques
CA 2545597 CA2545597A1 (en) 2006-03-15 2006-04-04 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
CA2,545,597 2006-04-04
PCT/IB2007/001716 WO2007105111A2 (en) 2006-03-15 2007-03-15 Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2012266306A Division JP6104584B2 (ja) 2006-03-15 2012-12-05 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用

Publications (3)

Publication Number Publication Date
JP2009529868A JP2009529868A (ja) 2009-08-27
JP2009529868A5 true JP2009529868A5 (enExample) 2010-04-08
JP5923232B2 JP5923232B2 (ja) 2016-05-24

Family

ID=38481184

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2008558940A Active JP5923232B2 (ja) 2006-03-15 2007-03-15 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用
JP2012266306A Expired - Fee Related JP6104584B2 (ja) 2006-03-15 2012-12-05 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2012266306A Expired - Fee Related JP6104584B2 (ja) 2006-03-15 2012-12-05 チクングンヤウイルスの新規な分離されかつ精製された株、並びにそのポリヌクレオチド及びポリペプチド配列、診断及び免疫原性の使用

Country Status (12)

Country Link
US (2) US20100055105A1 (enExample)
EP (2) EP2001900B1 (enExample)
JP (2) JP5923232B2 (enExample)
AU (1) AU2007226231B2 (enExample)
CA (2) CA2545597A1 (enExample)
DK (1) DK2001900T3 (enExample)
ES (1) ES2543839T3 (enExample)
HU (1) HUE025076T2 (enExample)
PL (1) PL2001900T3 (enExample)
PT (1) PT2001900E (enExample)
SI (1) SI2001900T1 (enExample)
WO (1) WO2007105111A2 (enExample)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2545597A1 (en) * 2006-03-15 2007-09-15 Institut Pasteur Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
EP2073839B1 (en) * 2006-09-01 2016-10-19 Bharat Biotech International Limited A vaccine for chikungunya virus infection
CA2598966A1 (en) * 2007-09-07 2009-03-07 Institut Pasteur Anti-chikungunya monoclonal antibodies and uses thereof
FR2921064A1 (fr) * 2007-09-14 2009-03-20 Biomerieux Sa Oligonucleotides, utilisation, methode de detection et kit permettant de diagnostiquer la presence du gene e1 du virus du chikungunya
JP5744719B2 (ja) * 2008-04-04 2015-07-08 ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア チクングニヤウィルスタンパク質の共通配列、これをコードする核酸分子、並びにこれを使用する組成物および方法
EP2808405B1 (en) 2008-04-21 2018-06-06 Gen-Probe Incorporated Method for Detecting Chikungunya Virus
JP2012518431A (ja) * 2009-02-25 2012-08-16 ビッグテック プライベート リミテッド チクングニア検出用のプローブおよびプライマー
CN103476788A (zh) * 2010-12-10 2013-12-25 新加坡科技研究局 免疫原性屈曲病毒肽
WO2012131580A1 (en) * 2011-03-28 2012-10-04 Scms, Institute Of Bioscience And Biotechnology Research And Development Method of detecting chikungunya virus utilizing a recombinant el coat peptide antigen
EP2712871A1 (en) 2012-09-27 2014-04-02 Institut Pasteur Recombinant Measles virus expressing Chikungunya virus polypeptides and their applications
US9701719B2 (en) 2012-09-27 2017-07-11 Research Development Foundation Attenuated Chikungunya virus
US11104916B2 (en) 2016-07-15 2021-08-31 Etubics Corporation Compositions and methods for alphavirus vaccination
TW202300515A (zh) 2016-10-20 2023-01-01 法商賽諾菲公司 抗ｃｈｉｋｖ抗體及其用途
KR102757369B1 (ko) * 2017-09-21 2025-01-20 발네바 에스이 면역원성 치쿤구니야 바이러스 chikv-델타5nsp3을 포함하는 약제학적 조성물의 생산 방법
WO2020069054A1 (en) * 2018-09-27 2020-04-02 Texas Tech University System Stable cell line secreting chikungunya virus (chikv) virus like particles (vlp) for vaccines
PH12023550246A1 (en) * 2020-07-31 2024-06-24 Replicate Bioscience Inc Modified chikungunya viruses and sindbis viruses and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1922084A4 (en) * 2005-08-11 2011-01-12 Univ Texas INFECTIOUS CLONING OF CHICUNGUNYA VIRUS AND ITS USE
CA2545597A1 (en) * 2006-03-15 2007-09-15 Institut Pasteur Novel isolated and purified strains of chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof
EP2073839B1 (en) * 2006-09-01 2016-10-19 Bharat Biotech International Limited A vaccine for chikungunya virus infection

Similar Documents

Publication Publication Date Title
JP2009529868A5 (enExample)
CN111218459B (zh) 一种以人复制缺陷腺病毒为载体的重组新型冠状病毒疫苗
AU641211B2 (en) Vaccines
EP3459965B1 (en) Methods of predicting ancestral virus sequences and uses thereof
CN112584849A (zh) 包含核酸及car修饰的免疫细胞的治疗剂及其应用
CN112980852B (zh) 新型冠状病毒b.1.351南非突变株rbd的基因及其应用
CN115710311A (zh) 冠状病毒的抗体或其抗原结合片段
CN111926040B (zh) 一种新型冠状病毒rbd核苷酸序列、优化方法与应用
CN111218477B (zh) 靶向感染哺乳动物细胞的禽4型腺病毒载体及其应用
CN106164090B (zh) TRAIL穿膜肽样突变体MuR6、制备方法及应用
CN104829732A (zh) 一种重组蛋白及其在昆虫杆状病毒表达系统中的表达方法
WO2004106360A3 (en) Viral vectors with improved properties
CN113046370B (zh) 新型冠状病毒b．1．1．7英国突变株rbd的基因及其应用
JP2010514698A5 (enExample)
CN113073106B (zh) 新型冠状病毒b.1.525尼日利亚突变株rbd的基因及其应用
Nicholas et al. A 16-amino acid peptide of respiratory syncytial virus 1A protein contains two overlapping T cell-stimulating sites distinguishable by class II MHC restriction elements.
CN106132986B (zh) TRAIL穿膜肽样突变体MuR5、制备方法及应用
JP5073653B2 (ja) 高レベルのタンパク質を産生する発現ベクター及び方法
CN119431524A (zh) Rsv融合前构象f蛋白的突变体及其应用
CN117683726A (zh) 一种稳定外分泌表达猪流行性腹泻病毒s蛋白的cho细胞系的构建方法
CN107034225B (zh) 制备埃博拉病毒糖蛋白与基质蛋白融合突变体的方法
CN113186204B (zh) 新型冠状病毒巴西株p．1突变株rbd的基因及其应用
CN107760719B (zh) 柯萨奇病毒在过继免疫基因递送系统中的应用
CN112725380A (zh) 稳定表达外源蛋白CHO细胞高效表达体系及其筛选方法和在PCV2 Cap蛋白中的应用
CN115850491B (zh) 针对肝癌相关抗原dlk1为靶点的car-t构建方法